世界中西医结合杂志
世界中西醫結閤雜誌
세계중서의결합잡지
World Journal of Integrated Traditional and Western Medicine
2015年
10期
1394-1397,1401
,共5页
李然伟%徐冰%张其慧%李蕊
李然偉%徐冰%張其慧%李蕊
리연위%서빙%장기혜%리예
糖尿病%缺血性卒中%柔肝健脾通络
糖尿病%缺血性卒中%柔肝健脾通絡
당뇨병%결혈성졸중%유간건비통락
Diabetic patients with ischemic stroke%Rougan Jianpitongluo%Clinical observation
目的:观察柔肝健脾通络法治疗糖尿病合并缺血性卒中的临床疗效。方法198例患者按就诊先后顺序随机分为中药治疗组99例,脱落10例,对照组99例,脱落11例。中药治疗组常规治疗加服“柔肝健脾通络”中药汤剂,对照组以常规治疗为主,两组疗程均为28 d。结果两组病例治疗后总有效率比较差异无统计学意义;两组病例治疗前后 NHISS 评分、焦虑量表评分、抑郁量表评分、生理领域、心理领域及社会关系领域评分比较差异有统计学意义,且中药治疗组优于对照组,差异有统计学意义。结论柔肝健脾通络中药治疗糖尿病合并缺血性卒中在改善患者的生活质量及缓解患病后的焦虑抑郁确有疗效,可很好地改善患者的精神状态,提高生存质量。
目的:觀察柔肝健脾通絡法治療糖尿病閤併缺血性卒中的臨床療效。方法198例患者按就診先後順序隨機分為中藥治療組99例,脫落10例,對照組99例,脫落11例。中藥治療組常規治療加服“柔肝健脾通絡”中藥湯劑,對照組以常規治療為主,兩組療程均為28 d。結果兩組病例治療後總有效率比較差異無統計學意義;兩組病例治療前後 NHISS 評分、焦慮量錶評分、抑鬱量錶評分、生理領域、心理領域及社會關繫領域評分比較差異有統計學意義,且中藥治療組優于對照組,差異有統計學意義。結論柔肝健脾通絡中藥治療糖尿病閤併缺血性卒中在改善患者的生活質量及緩解患病後的焦慮抑鬱確有療效,可很好地改善患者的精神狀態,提高生存質量。
목적:관찰유간건비통락법치료당뇨병합병결혈성졸중적림상료효。방법198례환자안취진선후순서수궤분위중약치료조99례,탈락10례,대조조99례,탈락11례。중약치료조상규치료가복“유간건비통락”중약탕제,대조조이상규치료위주,량조료정균위28 d。결과량조병례치료후총유효솔비교차이무통계학의의;량조병례치료전후 NHISS 평분、초필량표평분、억욱량표평분、생리영역、심리영역급사회관계영역평분비교차이유통계학의의,차중약치료조우우대조조,차이유통계학의의。결론유간건비통락중약치료당뇨병합병결혈성졸중재개선환자적생활질량급완해환병후적초필억욱학유료효,가흔호지개선환자적정신상태,제고생존질량。
Objective To observe the clinical efficacy on diabetic patients with ischemic stroke treated with Rougan Jianpitongluo Formula. Methods A total of 198 cases were randomized into treatment group(n = 99,10 cases dropped)and control group(n = 99,11 cases dropped). The treatment group applied Chinese medicine Rougan Jianpitongluo decoction wone dose a day. In the control group,conventional treat-ment was applied. The duration of treatment was 28 days in the both groups. Results The scores of NHISS were improved in both groups,but the group comparison indicated that the result in the treatment group was not better than that in the control group(P > 0. 05). The scores of HAMA SDS and WHOQOL - BREF were improved in both groups. The survival quality of patients was improved obviously and the difference was sig-nificant before and after treatment(P < 0. 05). The group comparison indicated that the result in the treatment group was better than that in the control group(P < 0. 05). The total effective rate in the treatment group was higher than that in the control group. Conclusion Rougan Jianpitongluo Formula achieves the definite effi-cacy on diabetic patients with ischemic stroke. It relieves greatly the clinical symptoms and physical signs and improves the survival quality of patients.